Chronic Hepatitis C and Diabetes Mellitus by İsmail BALIK, Nisbet YILMAZ, Nuran TÜRKÇAPAR, Hadi YAŞA

“…Thereforey, we decide to examine the patients with chronic viral hepatitis (B and C) for DM and the patients with type-2 DM for HBsAg and anti-HCV antibodies. …”
Get full text

Molecular Pathogenesis of Radiation-Induced Cell Toxicity in Stem Cells by Wonhee Hur, Seung Kew Yoon

Get full text

Violence, Discrimination, Psychological Distress, and HIV Vulnerability Among Men Who Have Sex With Men in Memphis, Tennessee by Meredith R. Denney, Latrice C. Pichon, Meredith L. Brantley

Get full text

Hepatitis E virus infection in selected Brazilian populations by Karen S Trinta, Maria Isabel M Liberto, Vanessa S de Paula, Clara FT Yoshida, Ana MC Gaspar

“…A total of 1,115 subjects were tested including 146 patients with acute Non-A Non-B Non-C (NANBNC) viral hepatitis, 65 hemodialysis patients, 93 blood donors, 102 intravenous drug users (IVDUs), 304 pregnant women, 145 individuals living in the rural area and 260 individuals living in the urban area. …”
Get full text

PREVALENCE OF ANTI-HBC IN HBSAG-NEGATIVE POPULATION by Daniel Ivanov, Tencho Tenev, Elica Golkocheva-Markova

“…The current study aimed to evaluate the presence of anti-HBc in patients negative for HBsAg whose clinical diagnosis was acute viral hepatitis. Material and methods. A total of 88 specimens were examined, of which 75 sera were from prospective patients diagnosed with acute viral hepatitis, and 13 sera from breast milk donors. …”
Get full text

ENHANCING THE PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HEPATITIS B by Tan Soek Siam

“…Globally according to the WHO progress report on viral hepatitis in 2021, 296 million people are living with chronic hepatitis B virus (HBV) infection and 820,000 deaths per year were due to HBV related liver cirrhosis and cancer. …”
Get full text

L. pneumophila Infection Diagnosed by tNGS in a Lady with Lymphadenopathy by Li S, Tong J, Li H, Mao C, Shen W, Lei Y, Hu P

“…Shiying Li,1 Jin Tong,2 Hu Li,1 Chenxue Mao,3 Wei Shen,1 Yu Lei,1 Peng Hu1 1Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Respiratory Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People’s Republic of China; 3Department of Laboratory Diagnosis, ChongQing KingMed Center for Clinical Laboratory Co., Ltd, Chongqing, 400050, People’s Republic of ChinaCorrespondence: Peng Hu, Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, 74# Linjiang Road, Chongqing, 400010, People’s Republic of China, Email hp_cq@163.com; hupengcq@hospital.cqmu.edu.cnAbstract: We report a case of a 34-year-old lady with multiple joint pain. …”
Get full text

Spatial Analysis of Food and Waterborne Diseases in Sabah, Malaysia by Syed Sharizman Syed Abdul Rahim, Shamsul Azhar Shah, Shaharudin Idrus, Zahir Izuan Azhar, Mohd Rohaizat Hassan, Nazarudin Safian

“…All reported cases of cholera, dysentery, food poisoning, typhoid, and viral hepatitis A from these areas and district health offices were included. …”

Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysisResearch in context by Ioana D. Olaru, Mina Beliz Meier, Fuad Mirzayev, Nevena Prodanovic, Philip J. Kitchen, Samuel G. Schumacher, Claudia M. Denkinger

“…Summary: Background: There is a substantial overlap in the epidemiology of chronic hepatitis B (HBV), hepatitis C (HCV) and tuberculosis (TB) due to overlapping risk factors. Testing for viral hepatitis is not widely recommended for patients with TB. …”
Get full text

Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region by Mikhail Yu. Kartashov, Kirill A. Svirin, Ekaterina I. Krivosheina, Elena V. Chub, Vladimir A. Ternovoi, Galina V. Kochneva

“…Introduction. Parenteral viral hepatitis (B, C, D) and HIV share modes of transmission and risk groups, in which the probability of infection with two or more of these viruses simultaneously is increased. …”
Get full text

Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program by Hope Kanise, Joep J. van Oosterhout, Pachawo Bisani, John Songo, Bilaal W. Matola, Chifundo Chipungu, Katherine Simon, Carrie Cox, Mina C. Hosseinipour, Jean-Batiste Sagno, Risa M. Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller

Get full text

Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018 by Tali Wagner, Neta S. Zuckerman, Tami Halperin, Daniel Chemtob, Itzchak Levy, Daniel Elbirt, Eduardo Shachar, Karen Olshtain-Pops, Hila Elinav, Michal Chowers, Valery Itsomin, Klaris Riesenberg, Marina Wax, Rachel Shirazi, Yael Gozlan, Natasha Matus, Shirley Girshengorn, Rotem Marom, Ella Mendelson, Dan Turner, Orna Mor

Get full text

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges by Joachim Lupberger, Thomas F. Baumert

“…Chronic viral hepatitis is a key risk factor for liver fibrosis and hepatocellular carcinoma (HCC) [...]…”
Get full text

Small‐molecule drugs as RNA‐targeted degraders by Luyi Huang, Jun Zou

Get full text

STATIN SAFETY REVISITED DATA by O. M. Drapkina

“…Features of statins use in nonalcoholic fatty liver disease, viral hepatitis C are considered separately.</p>…”
Get full text

Hepatite vírica e gravidez. by Anabela S Figueiredo, Artur S Cruz

“…Viral hepatitis is a common cause of morbidity and mortality. …”
Get full text

CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration... by Yunfei Zhao, Yun Li, Fan Wang, Xuelan Gan, Tianye Zheng, Mengyue Chen, Li Wei, Jun Chen, Chao Yu

Get full text

Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States by Nicole A. Swartwood, Christian Testa, Ted Cohen, Suzanne M. Marks, Andrew N. Hill, Garrett Beeler Asay, Jennifer Cochran, Kevin Cranston, Liisa M. Randall, Andrew Tibbs, C. Robert Horsburgh, Joshua A. Salomon, Nicolas A. Menzies

Get full text

Comparison of Nanopore and Synthesis-Based Next-Generation Sequencing Platforms for SARS-CoV-2 Variant Monitoring in Wastewater by David Garcia-Pedemonte, Albert Carcereny, Josep Gregori, Josep Quer, Damir Garcia-Cehic, Laura Guerrero, Adrià Ceretó-Massagué, Islem Abid, Albert Bosch, Maria Isabel Costafreda, Rosa M. Pintó, Susana Guix

Get full text

Hepatitis E Virus by Christina Levick

“…Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the developing world. It is a waterborne virus that can cause epidemics in the face of overcrowding and poor sanitation. …”
Get full text